Old Port Advisors,
Northside Capital Management, and
Balefire have either maintained or recently acquired new positions in MetLife, Inc. ($MET), pointing towards a relative confidence in the company's prospects. However, others like
Fifth Third Bancorp,
Procyon Advisors, and
InvesTrust have decreased their holdings. Notably,
Piper Sandler downgraded MET's stock rating citing lack of catalysts yet
Wolfe Research initiated its coverage with an outperform recommendation. After missing Q2 revenue estimates, MetLife announced they expect their variable investment income will meet Q3 targets. Furthermore, reports of MetLife's launching a cancer support offering might reinforce its leadership in employee benefits. However, shareholders have been recommended to reject a \"mini-tender\" offer by
Potemkin Limited, deeming it significantly discounted. Ahead of Q2 earnings, discussions on how to trade MET stock have surged, and while the outlook remains speculative, some assert reasons to sell MET, others recommend buying. Amid mixed signals, MET continues to quietly rally to new highs in its valuation.
Metlife MET News Analytics from Fri, 07 Mar 2025 08:00:00 GMT to Sat, 27 Sep 2025 08:00:13 GMT -
Rating -1
- Innovation 3
- Information 6
- Rumor 1
